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PseudogeneAcross the eubacteria, antigenic variation has emerged as a strategy to evade host immunity. However,
phenotypic variation in some of these antigens also allows the bacteria to exploit variable host niches as well.
The speciﬁc mechanisms are not shared-derived characters although there is considerable convergent evolution
and numerous commonalities reﬂecting considerations of natural selection and biochemical restraints. Unlike in
viruses, mechanisms of antigenic variation in most bacteria involve larger DNA movement such as gene conver-
sion or DNA rearrangement, although some antigens vary due to point mutations or modiﬁed transcriptional
regulation. The convergent evolution that promotes antigenic variation integrates various evolutionary forces:
these include mutations underlying variant production; drift which could remove alleles especially early in
infection or during life history phases in arthropod vectors (when the bacterial population size goes through a
bottleneck); selection not only for any particular variant but also for themechanism for the production of variants
(i.e., selection for mutability); and overcoming negative selection against variant production. This review high-
lights the complexities of drivers of antigenic variation, in particular extending evaluation beyond the commonly
cited theory of immune evasion. A deeper understanding of the diversity of purpose andmechanisms of antigenic
variation in bacteria will contribute to greater insight into bacterial pathogenesis, ecology and coevolution with
hosts.
© 2015 Foley. Published by Elsevier B.V. on behalf of the Research Network of Computational and Structural
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The survival of a pathogen requires evasion of host immunity, either
by switching hosts, becoming free-living some of the time, ﬁnding sites
within a host that are “privileged” or hidden from host immunity, or
switching the composition of an antigen. Pathogens commonly interact
with hosts through proteins or other macromolecules on their cell
surface; those that incite immune response from the host are designat-
ed as antigens. Phenotypic variation is subject to evolution if that
variation allows these molecules the pathogen to evade host immunity
or perform some other function, e.g., utilize diverse host niches. The
ability to vary antigen structure has evolved independently multiple
times across kingdoms and phyla of eukaryotes and prokaryotes,
reaching particular importance in obligately parasitic organisms that
cause chronic infection in hosts. For example, because vector-borne
and sexually transmitted pathogens often rely for survival on infection
that persists long enough for a new vector or host to acquire the infec-
tion, chronic infection and antigenic variation are common in these
pathogens [1]. Mechanisms of production of variant antigen genes
vary in speciﬁcs, but for most eukaryotes and prokaryotes (in contrast
with viruses, which often utilize point mutations), larger scale variation
is the rule [1], well reviewed in [2]. There are epigenetic, transcriptional,
and translational regulatory mechanisms for varying antigens as well,
which are outside the scope of the present paper. The bacteria span
alpha-Proteobacteria in the order Rickettsiales (Anaplasma, Ehrlichia,
andWolbachia genera); beta-Proteobacteria in the order Neisseriales;
Treponema and Borrelia species in the phylum Spirochaetes, family
Spirochaetacea, and even Mollicutes (Mycoplasma spp., phylum
Terericutes). This review will describe a suite of prokaryotic pathogens
that vary antigens as part of a strategy to evade host immunity and
promote chronic infection. Terminology will be used consistent with
the literature associated with each pathogen, but will be deﬁned. I
describe mechanisms for production of variants, and synthesize
evolutionary forces and constraints that shape the coevolutionary
phenomenon of antigenic variation among diverse bacterial genera.
1.1. Anaplasma phagocytophilum and Anaplasma marginale
An extensive body of literature evaluates antigenic variation in the
Anaplasmataceae, reviewed earlier [3]. Here we update literature with
some recent ﬁndings and synthesis, broadening the discussion to
other members of the family. A. phagocytophilum is an obligately
parasitic, intra-neutrophilic, tick-transmitted bacterial pathogen that
causes granulocytic anaplasmosis (GA) of humans and other animals.
Over the course of infection, hosts acquire temporary resistance to GA
as they develop immunity speciﬁc for the major antigen, major surface
protein 2 (Msp2). The function of this protein is not completely known.
The Msp2 forms multimeric complexes in the bacterial membrane and
then, on the human neutrophil, Msp2 cooperatively binds α1,3 fucosyl
transferases that construct the sialyl Lewis X (which typically caps the
P-selectin glycoprotein ligand-1) [4], steps necessary for bacterial inter-
nalization into cell. As hosts develop antibodies against expressedMsp2
variants, the bacterium then utilizes Rec-F dependent mechanisms to
recombine “functional pseudogenes” of the pfam01617 family
(common within Anaplasmataceae) sequentially into a hypervariable
region of an “expression cassette” with conserved 5′ and 3′ ends. The
expression cassette refers to the single locus in the genome where a
full-length coding sequence and promoter serve for transcription of an
RNA for the surface protein. Variation in the expression cassette
presumably bypasses host immunity and contributes in some host
species to persistent infection [5,6]. Indeed, antibodies produced against
speciﬁc Msp2 variants diminish rapidly as new variants emerge,
consistent with antigenic variation as an immune evasion strategy [7].
In the case of A. phagocytophilum, pseudogenes are considered
functional in that they serve as donor DNA into a functional expression
cassette. Approximately 100 pseudogenes are present in the originalfully sequenced genome, human-origin HZ, representing the possibility
for almost unlimited antigenic diversity [8]. This is remarkable given the
small genome size of only 1.4 Mb [8]. Of these pseudogenes, most have
high identity to some expression cassette that has been sequenced from
a naturally occurring host, suggesting that they have been used as a re-
combination donor [9]. Interestingly, high matches of HZ pseudogenes
occurred for predominantly North American, canine, and human
hosts, possibly reﬂecting the origin of the genome from which these
pseudogenes were sequenced [9]. In other words, if the full genome
from which pseudogenes were being evaluated was a European or
cervid strain, it is possible that higher matches would be to European
or ungulate expression cassette.
Pseudogenes with high identity to naturally occurring expression
cassettes among diverse hosts showed some clustering on a phyloge-
netic tree and in space on the genome, although many pseudogenes
did not ﬁt in convenient clusters [9]. There was some evidence for
multiple tandem repeats of pseudogenes but these did not cluster on
the phylogenetic tree, suggesting that they were not derived from
local duplications. Pseudogenes near the putative origin of replication
were more likely to match highly to some host expression cassette. All
of these data suggest a phenotype of hyper-recombination with natural
selection retaining pseudogenes in the genome, in particular locations.
A. marginale, a related pathogen that infects red blood cells and
causes anemia of deer and cattle, uses a similar recombination mecha-
nism to insert pseudogene fragments into a single polycistronic expres-
sion cassette with a central hypervariable region for its Msp2, although
with some important differences compared to A. phagocytophilum [10].
In contrast toA. phagocytophilum, there are only 5–7 pseudogenes in the
A. marginale St. Marie's genome, distributed across the genome [11,12].
In fact, depending on the strain, some of the pseudogenes are duplicates
or are so truncated that their role in gene conversion is unclear, and the
fragments that are actually involved in protein switching have been
called “donor alleles” [13]. There are several different mechanisms by
which variants are produced, such as an “anchored gene conversion”
in which part of a recombination complex is inserted into an invariant
region and another into a hypervariable region; small insertions within
the hypervariable region; or scattered substitutions across the region
[11,13]. In part because mosaics of the expression cassette can be
constructed through segmental recombination, very high diversity can
occur in an approximately 100 amino acid antigenically variable domain
[13]. High and comparable levels of diversity in msp2 alleles occur
among strains and among pseudogenes within each individual strain,
which was interpreted to indicate that there is selection within host
individuals and host populations to retain multiple alleles [14]. There
is strong evidence that the production of novel Msp2 proteins contrib-
utes to the evasion of host immunity. Rickettsemia in cattle is highly
cyclical with levels varying from102/ml to 107/ml over 6week intervals,
ultimately persisting for years [15,16]. The central hypervariable region
ofmsp2 encodes B-cell epitopes andmsp2 variants emerge shortly after
deﬁned immunoglobulins are produced that recognize an older Msp2
variant [15,17]. Superinfection (i.e., infection with a second strain in
already rickettsemic animal) is possible as long as the new strain
has at least one unique donor allele [14]. The msp3 gene family of
A. marginale also is polymorphic [18] and the simultaneous switching
of Msp2 andMsp3 is proposed to extend immune evasion considerable
[17].
1.2. Ehrlichia Spp.
The genus Ehrlichia, after some recent taxonomic reclassiﬁcation,
includes the closely related species Ehrlichia chaffeensis and Ehrlichia
ewingii which cause monocytic and granulocytic ehrlichiosis, respec-
tively, in humans, Ehrlichia canis which causes monocytic ehrlichiosis
primarily in dogs, and Ehrlichia ruminantium which causes heartwater
in ungulates. These obligately intra-cellular and tick-transmitted
bacteria cluster together in the family Anaplasmataceae with members
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an immunodominant, surface-exposed, varying antigens with both
conserved and variable regions, named MAP-1 for E. ruminantium, P28
for E. chaffeensis, and p28/p30 for E. canis. Recombinant P28 protein
confers immunity to E. chaffeensis challenge in a mouse model [19] and
a MAP-1 DNA vaccine protects mice from E. ruminantium [20].
There appear to be importantdifferences in themultiple-gene family
that encodes these Ehrlichia spp. antigens, compared with that in
Anaplasma and related species. In Ehrlichia spp., this family is fairly
small and consists of 17–22 tandemly arranged, mostly complete
genes or gene fragments with functional promoters and 200–600 bp
intergenic spaces [19–23]. Statistical and genetic analysis of
E. ruminantium full genomes indicated that the map-1 genes had
evidence of a very high rate of synonymous substitutions per site,
consistent with past, frequent homologous recombination [24,25].
Positive selection maintaining map-1 variants was indicated by one
analysis [26], but not supported in another [25]. However, unlike diver-
sity generated by gene conversion in Anaplasma spp., the expressed
diversity of the Ehrlichia sp. antigen may be due to differential
expression of intact gene copies, as shown for E. chaffeensis and
E. canis [21,27]. Transcription at the 5′ end of the E. canis omp gene
cluster appears to be polycistronic, but monocistronic at the 3′ end
[21]. Interestingly, even though E. canis occurs across most of
the world, many genes are relatively conserved, even including the
p28/p30 genes [28]. There are other major antigens, particularly the
secreted gp36 protein which elicits strong antibody responses, is highly
variable across strains, and is coded for by a gene with 11–18 tandem
repeats [28].
1.3. Wolbachia Spp.
Wolbachias are parasitic and commensal rickettsial bacteria of
invertebrates including insects, chelicerates, crustaceans, and
nematodes. AlthoughWolbachia usually is vertically transmitted, there
are cases of horizontal transmission even across host species [29].
Wolbachia infection commonly causes reproductive disorders such as
feminization, parthenogenesis, and cytoplasmic incompatibility, but
also direct morbidity such as neural tissue invasion and destruction
[30]. The species is divided phylogenetically into several supergroups
but there is evidence for extensive horizontal transfer due to recombi-
nation facilitated by phages, IS elements, and other mechanisms [31].
Wolbachias have amajor surface proteinWsp; thewsp gene is homolo-
gous to those from related rickettsias [32]. The gene has four conserved
transmembrane regions interspersed with hypervariable regions
(HVRs). Comparative analysis of 40wsp genes indicatedmultiple single
nucleotide polymorphisms but also separate recombination events as
the source of variability for each of theHVRs [33]. Recombination events
appeared to have occurred both within and among supergroups.
Importantly, the variability in Wsp highlights the problem with
inferring that “antigenic variation” evolves to escape immunity, because
Wolbachias primarily infect invertebrate organisms that lack adaptive
immunity.WolbachiaWsp is under purifying selection, based on analy-
sis of rates of synonymous vs. nonsynonymous substitutions, although
there also are discrete regions corresponding to the HVRs within the
gene apparently undergoing strongpositive selection [34]. Interestingly,
positive selection was not detected in mutualistic wolbachias from
nematodes and the positive selection detected in parasitic wolbachias
was concentrated outside the predicted transmembrane region of the
protein [26]. wsp paralogs designated wspB and wspCwere detected in
the wMel Wolbachia genome but they did not appear to be donors for
the HVRs and Wolbachia wsp HVRs were not homologous with genes
or fragments from other bacteria [33]. The positive selection regime
on wsp of parasitic wolbachias must be variable. In vertebrate-
pathogenic bacteria, antigens vary in concert with varying adaptive
immunities and this variable selection regime maintains genetic
variation in the pathogen. However invertebrates are thought to lackadaptive immunity, which raises the question whether the innate
immunity which arthropods do have might vary in a way that could
impose selection tomaintainwsp variation. In fact a study in Drosophila
showed precisely the type of adaptive immunitywhich could exert such
selection [35]. In that study, ﬂy immunity was speciﬁc to Streptococcus
pneumoniae, was long-lasting and capable of preventing further infec-
tions, and derived from priming of phagocytes. How general such
adaptive immunity is in arthropods and whether it is strong enough
to produce the variable signal seen in wsp are unknown. However,
wsp has another purpose—it is a host cell attachment protein: even in
the absence of immune pressure, the mosaic gene may have evolved
for occupation of different host niches. Less probably, variable wsp
may be a byproduct of the hyper-recombination that occurs in the
Wolbachia genome in general.
1.4. Relapsing Fever Borrelia Spp.
Relapsing fever is a potentially severe disease caused by several
related Borrelia species in North America and Africa and is transmitted
by various Argasid (soft) ticks or lice to humans and/or other animals.
As the name implies, the clinical signs wax and wane, often becoming
severe for several consecutive nights. It is thought that the interaction
of host immunity and bacterial immune evasion accounts for this
relapsing phenomenon. Antibody production alone may sufﬁce to
clear a relapsing fever infection, suggesting that humoral immunity is
the main driving force for these Borrelia spp. to vary antigens [36],
and the antibody class IgM [37]. The rate of antigen switching is about
10−4 to 10−2 per cell per generation while in the vertebrate host [38,
39] and, during the course of infection, the emergence of new serotypes
follows a “loose order” [40]. These bacteria utilizemultiple mechanisms
of switching antigens, including gene conversion, accumulation of point
mutations, DNA rearrangement, and transcript regulation.
The relapsing fever Borrelia spp. have an unusual collection of linear
chromosomes (sometimes described as a single chromosome with
multiple linear plasmids) and two subtelomeric genes coding for
antigens, the vlp and vsp genes (variable long and short proteins, respec-
tively, together referred to as vmp for variable major protein). Through-
out the genome (chromosome plus plasmids), each of these genes
contains about 30 copies [41]. An importantmechanism for the produc-
tion of variant Vmps is duplicative unidirectional, nonreciprocal transfer
of nucleotides from a donor allele into the expression site downstream
of a promoter [42], in which an upstream homology sequence (UHS) at
the 5′ end of the vmp and the downstream homology sequence (DHS)
serve as sites of initiation of gene conversion [43]. Other factors that
contribute to the process include the sigma-70 type promoter, the
ribosome binding site, an upstream long string of T residues that
enhances transcription, and three imperfect inverted repeats [44,45].
Inverted repeat sequences in the DHS probably help promote recombi-
nation [46]. Rarely, hybrid vmp genes may occur due to partial length
gene conversion but are short-lived in the face of host immunity [47]
and there appears also to be formation of mosaics among archived al-
leles [48]. A second mechanism for the generation of new variants is
via gene deletion between a pseudogene and expression site within a
single linear plasmid [49]. The vmp7 gene is linked to a pseudogene
for vmp26near the telomere of a linear plasmid. Gene conversionwithin
the expression site occurs at the sites of a 20 nucleotide fragment
common to both the vmp7 gene and vmp26 pseudogene, deleting
most of the expressed vmp7, and positioning the pseudogene immedi-
ately downstream of the ﬁrst two codons from the vmp7, thereby
allowing the vmp26 to be expressed.
A single infected individual typically has a set of bacteria expressing
a single Vmp population, with only rare variants present at any given
time [38]. In the tick vector, a vtp gene expresses a protein needed for
tick infectivity (Vtp for variable tick protein), and typically vtp and
vmp expression are toggled on and off during tick and host infection
[50]. However, if vmp is inactivated and Vtp continues to be expressed,
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targets the Vtp and eliminates the infection [51]. Statistical analysis of
repeats associated with varying antigens supported the role of strong
natural selection maintaining rare alleles in the population [48]. It is
likely that the balancing selection that maintains this diversity is
imposed by evolving host immunity, but utilization of multiple host
niches also could drive some of the retention of diversity, given the
documented association of some vspA expressed variants of Borrelia
turicataewith various tissue tropisms (e.g., neurologic tissue) [52]. The
pattern of occurrence of the variants relates to the relationships of the
silent allele with the extragenic sequence elements near the donor
locus and the expression site [53]. Greater homology between donor
alleles and the expression site did not result in higher probability of
recombination. In contrast, variants are more likely to be expressed if
they are highly homologous with the UHS at the 5′ end of the vmp
and closer to the DHS.
1.5. Lyme Borreliosis Borrelia Spp.
Lyme borreliosis (caused by Borrelia burgdorferi sensu lato) is the
most common vector-borne disease in North America and Europe
[54]. The bacteria occur across the Holarctic and are transmitted by
Ixodes spp. ticks [55]. Acute disease is characterized by an early localized
rash at the tick bite site (erythema migrans) sometimes followed by
extracutaneous, potentially chronic disease including fever, fatigue,
headache, and arthralgia, with possible oligoarthritis, carditis, lympho-
cytic meningitis, and peripheral neuropathy [56]. B. burgdorferi has
multiple antigens anchored to the outer membrane, although most do
not vary [57]. Despite homology with the Borrelia hermsii surface Vmp
protein, the OspC protein, which is expressed as B. burgdorferi transits
the tick salivary glands to the host, does not have within-cell variants
that can be expressed sequentially during host infection. Rather, persis-
tence in the host occurs in concert with production of variants at the vls
locus.
The vls expression site (vlsE) is located near the end of the 20 kbase
linear lp28-1 plasmid, contiguous with 15 unexpressed cassettes with
high homology to the vlsE [58]. The vlsE locus has a central variable
region consisting of six variant and six invariant regions, surrounded
by conserved sequence; each of the cassettes also has six variable
regions and conserved 5′ and 3′ ends [58]. The antigen is the 35 kDa
lipoprotein VlsE of which variant regions are exposed to host antibodies
while invariant regions maintain overall protein structure and function
[59]. Little else is known of the function of VlsE, except that it undergoes
antigenic variation and levels of expression appear to vary depending
on what host tissue is infected [60]. Variants are produced through
gene conversion via recombination between the vlsE expression site
and any of the 15 cassettes [61]. Independent disruption of 17 genes
involved in DNA recombinant and experimental infection with
the mutants documented a crucial role of ruvAB Holliday branch
migrase, encoded by ruvA and ruvB, in producing vlsE variants
[62]. In contrast to relapsing fever Borrelia spp., recombinants in
B. burgdorferi are not constrained by conserved upstream and down-
stream homology sequences. Short (as little as one bp) or long (up to
423 bp) recombinants can be produced and mosaics of the expression
cassette via segmental gene conversion are typical, meaning that the
possible repertoire of variants is enormous [63]. Entire replacement of
the cassette with a silent gene has not been observed [63]. At times,
“intermittent recombination events” occur, in which part of one silent
gene is inserted into the expression cassette, followed by parental
sequence and then more inserted DNA from a silent cassette [63].
Additional mutations in vlsE occur by single nucleotide changes, triplet
repeats that allow for expansion or contraction, insertions/deletions,
and “illegitimate recombination”, although the authors report that
“some extent of sequence complementarity and alignment is needed
to nucleate the recombination event” [63]. Despite all of the mecha-
nisms for production of variability, rarely do they cause disruption ofthe vlsE reading frame, suggesting that natural selection maintains full
functioning of this antigen.
An interesting question is what function is served by varying the
VlsE antigen. Variant production occurs as early as four days after infec-
tion in immunocompetent mice [64] and antibodies for each expressed
variant are produced in vivo in mice [65]. Any given infected individual
typically has many simultaneous circulating variants [66]. A mutant
strain lacking vlsE variant could not be maintained even in the white-
footedmouse reservoir, was not acquired by the natural deer tick vector
(because of low bacterial load in the host), but could induce a primary
infection in the rodent [67]. Variant VslE is not required for infection
in immunosuppressed mice [68] or for ﬁrst-time infection of immuno-
competent hosts [67]. Attempts to induce antigenic variation ex vivo
are generally unsuccessful [63]. It also is possible that a variant VlsE
strain might be capable of reinfecting a previously infected host, but
this was shown not to be the case in mice, likely because antibodies
against the other, invariant antigens prevented the new infection [69].
These data strongly suggest that immune evasion contributing to chron-
ic infection is a key reason for VlsE to vary. This also suggests that the
VlsE does not coat the other antigens and confer a protective effect.
Antibody production to VlsE is considerable and T-cell independent,
likely “conﬁning” host adaptive immune response against other
antigens. Unlike B. hermsii, there was not evidence for tissue tropism
of different genetic strains of B. burgdorferi, suggesting that immune
evasion was a more important force for evolution of varying antigens
than tissue tropism [63].
1.6. Neisseria gonorrhoeae and Neisseria meningitidis
The pathogenic Neisserias (N. gonorrhoeae and N. meningitidis)
are potentially epidemic, invasive, and fatal human pathogens.
N. meningitidis is a nasopharyngeal commensal in up to 25% of healthy
individuals but can develop into an epidemic pathogen,while gonococci
colonize the urogenital tract and are sexually-transmitted bacterial
pathogens. In both cases, epidemics typically represent invasion and
spread of genetically clonal Neisseria strains; for the meningococci,
capsular lineage A is responsible for huge outbreaks in Africa, and B
and C in the industrialized world [70]. The means by which pathogenic
and epidemic Neisseria strains emerge are not well understood but may
include exposure of naïve human populations to new lineages or
“unknown changes” yielding high-virulence clones [71].
A major adhesin for attachment to host epithelial cells is the
ﬁlamentous, surface-exposed Type IV pilus which is required for host
infectivity. Other potentially variant surface-exposed antigens include
lipooligosaccharide, opacity-associated proteins (Opas), and a capsule.
During passage and/or infection, cells can undergo phase shifts and
become nonpiliated or the antigen can vary genetically but remain
functional. Reportedly, pilus phase and antigenic variation in Neisseria
spp. facilitate immune invasion and new host niche exploitation [71].
RecA-independent slipped strand mispairing can occur within the pilC
genes [71] or pilin variation can occur through transformation from
exogenous DNA [72]. However, antigen variants are also produced by
RecA-dependent gene conversion from as many as 19 copies of the
pilS locus (for pilus Silent) that lie within six chromosomal loci into
the expressed pilE gene [73,74]. Silent copies lack promoters and
ribosomal-binding sites but contain variable and conserved sequence
on the 3′ end [71]. A pilS locus may contain a single gene copy or multi-
ple, arranged in a tandem array [75]. The unidirectional recombination
that produces pilE variants occurs at short (1–34 bp) areas of conserved
sequence [76]. Similar to B. burgdorferi, recombinants into pilE can vary
from very short to long, with insertions of 15 bp or less being common.
Ten genes associated with DNA repair have already been shown to be
involved in pilE switching, and to date, only the ruvA and ruvB involved
in antigenic variation in B. burgdorferi appears to be common between
the two pathogens [62]. Recently, a promoter was found 3′ of the
pilE locus on the antisense strand of N. meningitidis which directs
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bacterial growth phases and during salt stress [77]. This gives insight
into a means for environmental inﬂuences on antigenic variation in
this pathogen.
The Opa proteins (or protein II) are adhesins and have porin activity,
with a multiple-copy family in the genome of approximately 11 copies
[78]. In contrast to the pilin system consisting of a single expressed
copy andmultiple silent, defective copies,Opa gene copies are complete
and each bacterial clone can express no, one, or two different Opa
proteins [79]. Opa and pilE genesmap close to each other in the genome
[79]. The expression of Opa proteins regulates host cell tropism [75].
These proteins contain two surface-exposed hypervariable regions and
variation is produced both by recombination and by horizontal transfer
among clones [80]. However, one of the most important causes of
reversible phase variation in Opas is via translational control. The 5′
signal peptide coding sequence contains variable numbers of tandem
repeats of the sequence CTCTT: deletions and insertions of copies of
this sequence can lead to a frameshift and mediate On/Off switching
of Opas [81,82].
A mechanism to generate antigenic variation in Neisseria spp.
bacteria is to relax the stringency of the mismatch correction system
(MMC, sometimes termed mis-match repair, MMR) which repairs
DNA mismatches and mutation following replication [76]. Mutator
strains lacking functional genes for various components of the MMC
can have up to 100 times higher rates of homologous recombination
and lower thresholds for homology in order for recombination to
proceed [83]. Interestingly, N. gonorrhoeae strains with defective mutS
genes were less likely to have short mutations in the pilE but rather
experience recombination events with longer N200 bp tracts of replace-
ment from pilS donors [84]. The MutS protein of the MMC binds to an
upstream quartet of guanines (G4) to initiate the recombination and
then serves to prevent homologous recombination [85,86]. However,
use for different types of mutant MutS clariﬁed that the increase in
antigenic variation that occurs in N. gonorrhoeae is due to loss of mis-
match repair, not altered G4 binding [85]. Defects in the MMC are
over-represented in strains associated with invasive disease and
epidemics [83]. Neisseria spp. also have contingency loci consisting of
potentially large heterogeneous arrays of repetitive sequence tracts
that facilitate transformation and recombination [87]. Horizontal
transfer of genes with recombination has been recognized between
meningococci, from commensal Neisseria strains to pathogens, and
even between meningococci and gonococci [70].
Neisseria spp. vaccines have been produced for multiple strains
targeting capsular polysaccharides, although antigenic variation and
the impaired MMC in this genus complicate the problem. Particularly
for serogroup B of N. meningitidis [88], additional problems are weak
immunogenicity of some proteins and similarity to host antigens. A
promising target has been the outermembrane protein factor H binding
protein which host antibodies do target and candidate vaccines have
already been developed for clinical trials. Unfortunately, the protein
does show variability across geographical regions but there is also evi-
dence for recombination sites and lateral transfer to vary the antigen,
which may either reduce the value of a vaccine against this protein or
at least require a collection of various vaccine types against all the
various antigen strains [89].
1.7. Treponema pallidum
Syphilis is a sexually-transmitted disease caused by infection with
the spirochete T. pallidum. Untreated disease can be chronic and result
in primary chancres, disseminated rashes, neurological disorders, and
death, likely associated with emergence of variant antigens that evade
host immunity [90]. The T. pallidum repeat (Tpr) gene family consists
of two subfamilies (I and II) and 12members, ofwhich the TprK antigen,
presumably on the outer membrane, is most highly expressed [91]. The
TprK gene undergoes segmental conversion to produce variant antigens[92]. There is a single TprK expression site consisting of conserved
regions surrounding seven variable regions (V1–V7), each ﬂanked by
terminal 4 base pair repeat sequence. There also are internal repeat
sequences. These 4 base pair repeats correspond to repeats in more
than 50 donor sites ﬂanking TprD and these serve whole or in pieces
during segmental recombination to construct variant TprK. Each of
the donor sites is relatively small and spans only part or whole of a
single V region [92]. The differences observed within heterogeneous
populations consist of base pair changes, insertions, and deletions [93].
Because the agent has not yet proven cultivable, rabbits are a
commonly used animal model for syphilis [94]. Isolates that have been
propagated in rabbits or obtained from human lesions are variable,
although those bacteria from early chancres have less variation that
those from older infections and bacteria show increased diversity over
the course of passage [93]. Even within a single isolate, the amount of
diversity varies across the variable regions [93]. These results are
consistent with natural selection operating to promote variability and
that the different V regions may be subject to different intensities of
selection or at least vary in the rates of production of variation. There
is good evidence that the emergence of a population of treponemes
with variable TprK does occur in order to evade host immunity because
antiserum raised against TprK opsonizes T. pallidum [95], immunosup-
pressed hosts accumulate lower levels of genetic diversity compared
with competent hosts [96], and pre-immunized rabbits accumulated
variation more quickly than control rabbits [96]. A recent study created
clones of T. pallidum from the Chicago strain that did not vary in the TprK
and used these in the rabbit model, documenting emergence of escape
variants and the over-representation of the new variants in disseminat-
ed lesions, supporting earlier theories for the role of escape variants in
immune evasion [94].
1.8. Mycoplasma Spp.
Mycoplasma spp. are typically mucosa-associated, cell wall-less
bacteria with very small genomes and reduced protein coding capacity
compared with other prokaryotes. Surface antigen variation in Myco-
plasma spp. has been reported due to nucleotide insertion and deletions,
DNA slippage, DNA rearrangement, site-speciﬁc recombination, gene
conversion, and reciprocal recombination, in addition to transcriptional
and other regulatory mechanisms [97,98]. Mycoplasma genitalium is a
sexually transmitted bacteria that can cause urethritis, salpingitis,
cervicitis, and pelvic inﬂammatory disease. Infectionmay last for several
years [99]. The MgPa (or P140) and P110 proteins are associated with
the attachment organelle and are encoded bymgpB and mgpC, respec-
tively. Both genes are translated from a single expression site, of
which there is only copy in the genome. However, approximately 4%
of the genome contains MgPa repeat regions with variable homology
to mgpB and mgpC [100]. Based on examination of the M. genitalium
G-37T genome, bacteria maintained in vitro, and observation of chronic
infection, Iverson-Cabral documented extensive sequence variation
within a single strain and that variation was produced through recipro-
cal recombination [97]. Within this genome, there are nine MgPa
repeats and within most, segments homologous to mspB are inter-
spersed with regions homologous to mgpC. The 5′ end, particularly of
mgpC, matched to MgPa sequences and thus seems a target for homol-
ogous recombination. In vivo, during chronic infection, both genes
varied extensively and independently. Results of sequencing of the
expression site and MgPa regions were consistent with reciprocal
recombination but not gene conversion, although some recombinants
were asymmetrical. Occasionally, recombination appeared between
MgPa repeat regions.
Ma et al. also showed that mgpC variants emerged by reciprocal
recombination but also that variants emerged by gene conversion in a
natural human chronic infection [101]. All except one of the MgPa
repeats contained 3–5 “discreteminicassettes”with homology tomulti-
ple sites in mgpB and mgpC (referred to in this paper as MG191 and
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variable region, whichwas interpreted as consistent with a site-speciﬁc
recombination mechanism. In contrast, in vitro, mutants developed
from large genomic deletions after mgpB and mgpC expression site
cross-overs with MgPa regions [102]. The signiﬁcance of these changes
is not known as the work was done in vitro and non-attaching
(avirulent) phenotypes were chosen for analysis [102].
Mycoplasma pneumoniae, a major cause of tracheobronchitis and
community-acquired pneumonia, has a similar operon tomgp, contain-
ing the proteins P1 and the reading frames ORF4 and ORF6. RepMP
fragments homologous to the P1 and ORF6 genes are dispersed and
repeated 7–9 times in the genome, although little variation in expres-
sion of the P1 and ORF6 genes has been detected [103,104]. However,
one novel P1 variant was detected with homology to two of the
RepMP fragments, consistent with gene conversion [104]. A RecA
homolog has been detected in both M. genitalium and M. pneumoniae
which could be involved in recombination [105]. Additionally, charac-
terization of the MpnSSB protein ofM. pneumoniae revealed its strong,
selective single-stranded DNA binding activity and promotion of
Escherichia coli recA-dependent recombination [106]
Mycoplasma pulmonis, the murine respiratory pathogen, has a
cluster of genes called the vsa locuswhich encodes variable V1 antigens.
There is a single functional expression site in one strain but multiple in
another [107]. Nearby are silent vsa genes lacking functional promoters
at the 5′ end but containing tandem repeats and recombination sites.
Site-speciﬁc DNA inversions occur in which the promoter and the
protein amino terminal coding DNA from the expression site is
recombined into a previously silent gene [108]. The number of tandem
repeats depends on the silent gene origin and varies through slipped-
strand mispairing and illegitimate recombination [107]. A similar
mechanism occurs in the related Mycoplasma agalactiae vpma locus
[109].
Several avian mycoplasmas also show various methods of produc-
tion of variants. Despite being closely related and having homologous
antigen genes, the mechanisms used to induce variation are not the
same. In both Mycoplasma gallisepticum and Mycoplasma synoviae, an
important antigen is the variable lipoprotein hemagglutinin (VlhA)
adhesin. Depending on the strain of M. gallisepticum, there may be up
to 70 copies in the vlhA multiple-gene family [110] and a multiple-
gene family also occurs for this gene inM. synoviae [111]. The gene fam-
ilies, while related, show important dissimilarities. InM. gallisepticum,
tandemly repeated full-length genes, each with an intact ORF and
promoter, are controlled by a variable trinucleotide repeat motif
upstream of the promoter [110]. In contrast, only one intact gene exists
for M. synoviae, but approximately 70 silent copies each lacking a
promoter occur in tandem within the genome [112]. There are ﬁve
different sites within the expressed gene into which pseudogenes may
recombine to produce variants [111].
Mycoplasma spp. are fascinating for their incredibly parsimonious
genomes, despite an apparent need for evading host immunity.
Mycoplasma genomes are highly mutable with numerous mechanisms
for mutation and recombination. For example, Mycoplasmas in general
lack an SOS response and many repair proteins [113]. In theory,
mycoplasmas may have high rates of homologous, site-speciﬁc, and
illegitimate recombination in part to efﬁciently make use of large
protein families encoded by minimal nucleotides [114]. Overall, the
multiple and efﬁcient mechanisms for recombination utilized by
bacteria in this genus, including the rare reciprocal recombination,
suggest a life history strategy that is distinctive among bacteria.
2. Evolution of Antigenic Variation
Major antigens vary genetically over the course of infection in a
diversity of bacteria, particularly those with characteristically chronic
infection, often in concert with cyclic adaptations of host immunity to
expressed antigen variants. Unlike in viruses, mechanisms of antigenicvariation in most bacteria involve larger DNA movement such as gene
conversion or DNA rearrangement, with homologous recombination
being perhaps the most prevalent. In contrast, some antigens vary
due to point mutations or modiﬁed transcriptional regulation. The
convergent evolution that promotes antigenic variation integrates
various evolutionary forces: these includemutations underlying variant
production; drift which could remove alleles especially early in
infection or during life history phases in arthropod vectors (when the
bacterial population size goes through a bottleneck); selection not
only for any particular variant but also for the mechanism for the
production of variants (i.e., selection for mutability); and overcoming
negative selection against variant production.
2.1. The Origins of Variant Antigens
There is evidence that the origin of some antigens is from horizontal
transfer, e.g., the vlsE gene has a much higher G:C content than the rest
of the B. burgdorferi genome, suggesting an external source [115].
Presence of mobile elements among bacteria with antigenic variation
varies: Anaplasma and Ehrlichia spp. lack prophages and transposable
elements while Wolbachia pipientis has both phages and transposons
[8,116]. The functions of the varying antigens are not thoroughly under-
stood: somepathogens utilize the surface-exposed antigens for host cell
interactions while the function of some antigens, such as those of
T. pallidum is unknown.
Pathogens vary with respect to whether they express one or multi-
ple antigens and how these antigens interact. For example, the outer
membrane of T. pallidum reportedly has very few proteins and the
TprK may be one of the few [117], while in contrast Neisseria spp.
have Opa, pilin, and lipooligosaccharide antigens. In B. burgdorferi,
there also aremultiple antigens, so the fact that adaptive host responses
to at least three invariant antigens fail to contain infection while the
VlsE protein varies was enigmatic and led to the hypothesis that VlsE
might physically cover the other antigens. This was not supported how-
ever by evidence that reinfection with strains expressing variant VlsE
was not possible, suggesting that host immunity was directed against
other antigens [69]. A revised theory is that the dominant antigen
might manipulate host immunity during active infection, possibly
through T-cell independent mechanisms that allow for futile antibody
induction against the VlsE [69]. Anaplasma spp. may have multiple
antigens, e.g., the Msp2 and Msp3 of A. marginale, but variation can
occur in both. Thus evolution has not converged on a single strategy
for expression of a single vs. multiple variant or invariant antigens.
2.2. Types of Mutation and Mutational Constraints
Across the prokaryotes, a diversity of mechanisms is used to
generate diversity in antigens, including point mutations, DNA rear-
rangement, illegitimate recombination, reciprocal recombination, and
by far the most common, homologous recombination. True illegitimate
recombinationmay be uncommon; short, somewhat homologous tracts
of DNA appear to be required to “nucleate” recombination of antigens in
both B. burgdorferi and Neisseria spp. [63]. Duplication and recombina-
tion are common on B. burgdorferi linear plasmids, notably including
the inverted repeats on the DHS [115]. Once DNA repeats are present,
these repeats facilitate slipped-strand replication and/or recombination
and these areas can become contingency loci [118]. Examples of this are
the poly (dA–dT) tract at the vmp expression site of B. hermsii [43] and
the repeat tracts that comprise at least 5% of the pathogenic Neisseria's
genomes [119]. While the frequency or probability of antigen switching
could vary as a function of percent homology among conserved regions,
this is not always the case, with a notable exception being B. hermsii, in
which the probability of antigen switching differs as a function of
distance from downstream and upstream homology regions [53].
The terminology among bacteria varies, but many species capable of
varying antigens retain a library of unexpressed pseudogenes, silent
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expression site, for antigenic diversity. Large amounts of the genomes
of B. burgdorferi and A. phagocytophilum are made up of pseudogenes,
even though pseudogenes overall are uncommon in most bacteria
[115]. The pattern of gene conversion among these bacteria differs: for
B. burgdorferi, gene conversion into the vlsE cassette is “partial” and
boundaries for recombination are within the gene per se, unlike in
relapsing fever borrelias [61]. For Anaplasma spp., pseudogene
fragments are inserted between conserved regions of the expression
site. In contrast, even though Ehrlichia spp. can induce chronic infection
and have a similar multiple-gene family encoding an immunogenic
outer membrane protein, these genes are tandemly arranged full copies
that appear to allow for antigenic variation though differential expres-
sion, not gene conversion. Variant bacterial antigens also differ as to
the extent of the recipient gene that is replaced, i.e., essentially
completely in the “cassette” system of Anaplasma spp. vs. the small
fragments inserted for T. pallidum or variably sized pieces in
B. burgdorferi. Even where an entire cassette can be shufﬂed into a
recipient sequence, additional insertions or segmental gene conversion
can produce mosaic antigens such as occurs in A. marginale. Segmental
gene conversion and utilization of small donor sequences may allow
for the bacteria to carry a lower pseudogene load, because longer
donor DNA stretches are not required.
The location of silent gene copies may contribute to the mutability,
e.g., in A. phagocytophilum, in which most copies are located near the
putative origin of replication where multiple replication forks could
increase recombination probabilities [8,9]. Borrelia spp. telomeres are
reportedly “inherently recombinogenic” [120], increasing the likelihood
of variant production in B. hermsii Vmps. No obvious pattern exists that
pseudogenes are more likely to be inserted from a plasmid into a chro-
mosomal expression locus, rather, Anaplasma spp. lack plasmids and the
Borrelia spp. expression sites are on linear plasmids. In an unusual case,
opa and pilE genes of the Neisseria spp. map together, whichmay reﬂect
simply a recombinational hotspot but also a possible mechanism for
efﬁcient production of variation across antigens [121]. Pseudogene
position and the differential probability of expression of particular
pseudogenes could partially account for why there appears to be some
programming in the chronological order of expression of alleles, as
occurs in A. marginale and B. hermsii. Of course another reasonable
explanation is that some clones in which variant antigens have been
produced by recombination are relatively more ﬁt, possibly due to
differences in the functionality of antigen (outside its role in immune
evasion), and that these clones would predominate early in infection,
before host immune pressure mounts. There also is evidence in some
bacteria that particular pseudogenes are more likely to be incorporated
into an expression site compared to others, as in Neisseria spp. and
A. phagocytophilum in which certain pilS or msp2 alleles predominate
[9,76]. Clearly this could be because of biochemical constraints such as
chromosomal position, percent similarity of the conserved regions, or
length of the ﬂanking tracts vs. selective advantages of the particular
alleles. For A. phagocytophilum, however, it is likely that differential
ﬁtness plays some role because usage of some pseudogenes appears to
differ depending on which host it originates from.
It is not clear why the actual mechanisms of antigenic variation
overwhelmingly represent homologous recombination/gene conver-
sion. This does not appear to be a shared, derived character but rather
has evolved independentlymultiple times. There are othermechanisms
that produce variant antigens such as the reciprocal recombination that
is found in Mycoplasma spp. and the homologous recombination in
Neisseria spp. Even within the mycoplasmas, there are multiple
mechanisms of antigenic variation which appear to have evolved
independently [111]. Homologous recombination requires conserved
tracts of DNA to anchor the reaction in both donor and recipient and pri-
marily evolved as a mechanism to repair DNA after inaccurate replica-
tion and to incorporate genetic material in horizontal gene transfer
between bacteria. Several different enzymes are involved in bacterialhomologous recombination and, across the bacteria that utilize antigen-
ic variation, there are differences in the availability of speciﬁc enzymes.
For example, RecBCD is necessary for homologous recombination in
E. coli, but Anaplasma spp. lack the RecBCD enzyme complex and instead
vary antigens using RecF [6]. However, conserved DNA tracts ﬂanking
variable regions (that typically interact with host T and B-cells) are
common. It is possible thatmechanisms such as illegitimate recombina-
tion could be less reliable in producing functional but variant antigens
that could contribute to evasion of host immunity.
2.3. Drift
Drift refers to the loss of genetic variability that occurs through
random processes and is exacerbated at small sample sizes (e.g., during
founder events). Bacteria vary considerably in the infectious dose
needed to produce infection in the host, but in highly pathogenic
species, this can be fairly low. Additionally, vector-borne pathogens
commonly retain quite low copy numbers of bacteria in the invertebrate
vector although replication may produce many copies at the time of
transmission. The actual inoculum from the arthropod into the host
may contain few bacteria. Where drift is relevant, it would be expected
that early infectionswould involve relatively invariant bacteria and that
genetic diversity of antigens would emerge over the course of chronic
infection. In fact this has been observed in T. pallidum in which primary
skin chancres do have invariant bacterial populations compared with
bacteria from later-stage infections [93]. Neisseria strains from human
epidemics are distinctly clonal compared with commensal strains,
consistent with invasion of a new bacterial strain from a restricted
population: in principle, over time these epidemic strains would likely
accumulate genetic variability as well [83].
2.4. Natural Selection for Antigenic Variation
By far, the most commonly invoked explanation to account for the
phenomenon of antigenic variation is evasion of host immunity in
order to promote chronic infection, particularly in vector-borne and
sexually-transmitted diseases [122]. Immune selection could also be
invoked to show how antigen variation can facilitate reinfection or
superinfection of host individuals with new genetic variants of a patho-
gen. However, it is also important to incorporate into theory the fact
that antigens have other functions for their cells besides attracting
host immunity. In many cases, phenotypes that vary could confer
advantages for the pathogen such as allowing it to utilize diverse or
varying host niches.
Immune evasion is at least a partial explanation for antigenic
variation in all of the bacteria described in this paper, with the strength
of the evidence dependent on studies showing concerted adaptive
immune responses of the host with emergence of pathogen variants.
Such natural selection is a form of frequency-dependent selection and
was noted for B. hermsii where there is selection for rare variants [48].
Evidence for antigen variability conferring diverse tissue tropisms is
mixed: variant B. hermsii and A. phagocytophilum strains exploit differ-
ent hosts and tissues but this has not been shown for B. burgdorferi.
This could be particularly relevant for A. phagocytophilumwhich infects
a diversity of different host species [123]. Infections may be acute or
chronic, depending on the host, revealing that evasion of host immunity
is not always successful and suggesting that antigenic variation could
serve some other function. The source of the very large number of
pseudogenes in A. phagocytophilum, used in some hosts for antigenic
variation, is an interesting question. The related A. marginale has far
fewer pseudogenes yet is evolutionarily older [124], suggesting that
an ancestral condition could have been fewer pseudogenes and the
proliferation of pseudogenes has occurred more recently, possibly
conferring the host breadth that characterizes A. phagocytophilum but
not A. marginale. Exploitation of various host niches has also been
proposed as a driver for antigenic variation in M. pneumoniae, as host
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antigens [107] and forM. hominis [125].
Reinfection is possible in some but not all hosts with variant patho-
gens. For example, even strains of B. burgdorferiwith distinctly different
VlsE expression could not reinfectmice, likely because hosts already had
developed strong immune responses to other, invariant antigens [69].
However, if antigenic variation does allow for reinfection or superinfec-
tion, then this could facilitate horizontal transmission of pathogen DNA
between strains and promote rapid evolution.
2.5. Natural Selection for Hypermutability
In order to insure that new antigens will continue to be available
over the course of chronic infection, some bacteria have evolved a
state of hypermutability. This can be effected throughphysical construc-
tion of the genome (e.g., presence of anchoring repeats) such that
recombination becomes more likely, dependence on faulty mutation–
repair systems, or inaccurate replication machinery. There is evidence
for hypermutability of genomes in Borrelia spp. in which large amounts
of recombination, duplications, and pseudogenes suggest rapid evolu-
tion [115]. SomeMycoplasma spp. lack an SOS response and DNA repair
proteins. Interestingly, the rate of variant production is considerably
reduced in a recA deletion mutant of M. gallisepticum, suggesting a
role for this repair protein in antigen variation [102]. Overall, recA was
shown to have a minor role in general DNA repair of this pathogen,
and thus these results tht recA is maintained in this highly reduced
genome speciﬁcally for its ability to promote antigenic variation.
Defects in the mismatch repair system induce hyper mutability in
Neisseria spp.
2.6. Costs of Antigenic Variation: Natural Selection against Varying Antigens
One considerable beneﬁt of high recombination rates in intracellular
bacteria is to avoid “Muller's ratchet”, i.e., the accumulation of deleteri-
ous mutants [126]. However, it is important for the rate of mutation to
be set at an intermediate level: very fast rates escape host control but
risk producing too high a proportion of unﬁt progeny, but very slow
rates fail to allow the pathogen to evade host immunity [127]. Some
mechanisms for varying antigens could be riskier than others. For exam-
ple reliance on slipped–strand recombination or illegitimate recombi-
nation could result in a overall genomic instability, producing not only
less ﬁt genes but potentially less ﬁt genomes as well. Where gene
conversion is used as a strategy for varying antigens, particularly if a
repertoire of donor or pseudogenes is retained in the genome, a cost is
incurred by the bacterium in order to repeatedly replicate an otherwise
needlessly large genome. In general, bacterial genomes tend to evolve to
be as small as possible: in intracellular bacteria, this pattern is exagger-
ated with extreme loss of unneeded genes [128]. However, at least
transiently during evolution of a small genome, there may be an
increase in the number of pseudogenes and mobile genetic elements.
This pattern ﬁts for the extremely smallMycoplasma spp. which gener-
ate variability using a diversity of mechanisms. A remarkable exception
is A. phagocytophilum, an obligately intracellular pathogenwhich has an
enormous genome consisting ofmore than 100 functional pseudogenes.
An obvious cost of using hypermutability to generate novel antigens
is the risk of producing defective products from other genes as well,
although strong purifying natural selection could occur on many
genes to ensure that they don't vary. Purifying selection occurs even in
some parts of antigen genes needed for functionality, e.g., in a
B. hermsii vsp region corresponding to the signal peptide [48].
A. marginaleMsp2mosaics are selectively disadvantageous in immuno-
logically naïve animals [10,129,130], theoretically because Msp2
proteins may have a porin function in addition to serving as an antigen,
and immune-escape variants may have lower ﬁtness as porins [13].
Even recombination targeting antigen genes incurs a cost if the new
variants are less functional than the original, although this is difﬁcultto assess for those bacteria for which the actual function of the antigen
is poorly understood (e.g., TprK in T. pallidum). The pilus ofNeisseria spp.
is a very important virulence determinant and phase-shifted clones
without pili are less ﬁt except with respect to evading host immunity.
It may be that dysfunctionally mutated pilE genes occur but that
selection for functionality forces only some of these to persist in natural
infections. However, the strength of the natural selection imposed by
host immunity is considerable and in some cases could overcome the
otherwise deleterious effects of the mutation.
Across the eubacteria, antigenic variation has emerged as a strategy
to evade host immunity, while those same antigen molecules of have
non-immune related functions as well, e.g., allowing the pathogen to
exploit variable host niches. The speciﬁc mechanisms are not shared-
derived characters although there is considerable convergent evolution
and numerous commonalities reﬂecting considerations of natural
selection and biochemical restraints. This review highlights the
complexities of drivers of antigenic variation, in particular both those
responding to immune stimuli but also extending evaluation to non-
immune functions as well. A deeper understanding of the diversity of
purpose and mechanisms of “antigenic variation” in bacteria will
contribute to greater insight into bacterial pathogenesis, ecology and
coevolution with hosts.Acknowledgments
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